Table 1 Demographics at group level
From: L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas
18F-FET positive | 18F-FET negative | |||
|---|---|---|---|---|
Number of subjects | 20 | 20 | ||
Age (y, median, range) | 39.9 (25.9–69.3) | 37.8 (26.3–47.6) | ||
Sex (♀ /♂) | 8♀/12♂ | 9♀/11♂ | ||
WHO grade | II | 11 | 20 | |
III | 9 | 0 | ||
Mode of surgery | Biopsy | 14 | 19 | |
Resection | 6 | 1 | ||
SUVBG (median, range) | 1.04 (0.67–1.93) | 1.01 (0.35–1.20) | ||
SUVmax (median, range) | 2.91 (1.32–5.75) | 1.16 (0.40–1.81) | ||
TBRmax (median, range) | 2.29 (1.61–5.17) | 1.24 (0.84–1.58) | ||
SUVmean (median, range) | 1.94 (1.19–3.09) | |||
TBRmean (median, range) | 1.93 (1.68–2.38) | |||
BTV (median, range) | 19.52 (1.38–78.46) | |||
% LAT1-positive tumour cells by staining intensity (median, range) | 0 | 70 (0–98) | 80 (0–98) | |
1 | 20 (0–95) | 10 (0–95) | ||
2 | 5 (0–80) | 5 (0–50) | ||
LAT1 overall H-score (median, range) | 22.5 (2–180) | 25.5 (5–118) | ||
LAT1 H-score tumour cells (median, range) | 11.0 (0–180) | 10.5 (0–84) | ||
LAT1 H-score vessels (median, range) | 6.5 (0–42) | 4.5 (0–22) | ||